Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
M&A
Piramal Pharma to acquire 100 per cent stake in Hemmo Pharma for Rs 775 crores
This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs
Agilent continues to focus on strategic M&A, R&D investment to expand product portfolio
Samir Vyas, Country Manager, Agilent India says India companies are now moving into the global biopharma market and gives his…
Sun Pharma to acquire stake in WRS Bioproducts, Australia
WRS Bioproducts develops novel technologies to produce supplements and nutraceutical ingredients from diverse algae species
Amgen to buy Five Prime Therapeutics in $1.9 million deal
Through the latest deal, Amgen will get access to Five Prime’s lead drug candidate, bemarituzumab, which is ready to enter a…
Bain Capital, Cinven to acquire Lonza Specialty Ingredients for $4.7 billion
Lonza is doubling down on its accelerating drug business
Healthcare industry reported 70 deals worth $6.2 billion in January 2021: GlobalData
Deal value decreased by 89 per cent in Jan 2021, compared to Dec 2020
Nordic Capital makes a bid to purchase Advanz Pharma in $846 mn deal
Under the offer, shareholders would receive a price of $17.26 per Advanz Pharma share
Hikma intends to acquire assets in Egypt, Tunisia
Further talks with GSK will depend on the results of its due-diligence process
TA Associates acquires stake in OmniActive Health Technologies
Financial terms of the transaction were not disclosed